CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+16%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$324M
AUM Growth
+$28.5M
(+9.6%)
Cap. Flow
-$70.4K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
465
New
18
Increased
159
Reduced
244
Closed
13
Top Buys
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.28M |
| 2 |
Tesla
TSLA
|
$2.24M |
| 3 |
Apple
AAPL
|
$2.14M |
| 4 |
Meta Platforms (Facebook)
META
|
$2.1M |
| 5 |
Vaxcyte
PCVX
|
$2M |
Top Sells
| 1 |
iQIYI
IQ
|
$4.85M |
| 2 |
Amazon
AMZN
|
$4.7M |
| 3 |
Airbnb
ABNB
|
$3.2M |
| 4 |
Analog Devices
ADI
|
$2.94M |
| 5 |
KE Holdings
BEKE
|
$1.93M |
Sector Composition
| 1 | Technology | 41.8% |
| 2 | Consumer Discretionary | 21.38% |
| 3 | Healthcare | 19.26% |
| 4 | Communication Services | 6.74% |
| 5 | Financials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Marriott International Class A Common Stock
MAR
$71.9B
| $63.2K | 0.02% |
344
+251
| +270% | +$46.1K |
|
177
Charter Communications
CHTR
$35.7B
| $62.5K | 0.02% |
170
+124
| +270% | +$45.6K |
|
|
178
Airbnb
ABNB
$75.8B
| $60.6K | 0.02% |
473
-24,989
| -98% | -$3.2M |
|
179
NXP Semiconductors
NXPI
$57.2B
| $60.2K | 0.02% |
293
+215
| +276% | +$44.2K |
|
180
Legend Biotech
LEGN
$6.66B
| $58.6K | 0.02% |
849
-29
| -3% | -$2K |
|
181
CRISPR Therapeutics
CRSP
$4.99B
| $58K | 0.02% |
1,034
-31
| -3% | -$1.74K |
|
182
NovoCure
NVCR
$1.37B
| $57.8K | 0.02% |
1,392
-37
| -3% | -$1.54K |
|
|
SYNH
183
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $57.3K | 0.02% |
1,359
-40
| -3% | -$1.69K |
|
184
Cintas
CTAS
$82.4B
| $57.2K | 0.02% |
460
+336
| +271% | +$41.8K |
|
185
Madrigal Pharmaceuticals
MDGL
$9.65B
| $55.4K | 0.02% |
240
-6
| -2% | -$1.39K |
|
186
Microchip Technology
MCHP
$35.6B
| $55.1K | 0.02% |
615
+449
| +270% | +$40.2K |
|
187
Denali Therapeutics
DNLI
$2.26B
| $52.9K | 0.02% |
1,794
-57
| -3% | -$1.68K |
|
188
New Oriental
EDU
$7.98B
| $52.3K | 0.02% |
1,325
| – | – |
|
189
Acadia Pharmaceuticals
ACAD
$4.26B
| $51.1K | 0.02% |
2,132
-66
| -3% | -$1.58K |
|
|
BPMC
190
DELISTED
Blueprint Medicines
BPMC
| $50.1K | 0.02% |
793
-20
| -2% | -$1.26K |
|
191
Arrowhead Research
ARWR
$4.02B
| $50K | 0.02% |
1,401
-66
| -4% | -$2.35K |
|
192
Keurig Dr Pepper
KDP
$38.9B
| $49.8K | 0.02% |
1,584
+1,159
| +273% | +$36.4K |
|
193
Autodesk
ADSK
$69.5B
| $49.5K | 0.02% |
242
-3,773
| -94% | -$772K |
|
194
PACCAR
PCAR
$52B
| $49.4K | 0.02% |
590
+432
| +273% | +$36.1K |
|
195
Kraft Heinz
KHC
$32.3B
| $49.2K | 0.02% |
1,385
+1,015
| +274% | +$36K |
|
196
Copart
CPRT
$47B
| $49.2K | 0.02% |
1,078
+790
| +274% | +$36K |
|
197
American Electric Power
AEP
$57.8B
| $48.9K | 0.02% |
581
+425
| +272% | +$35.8K |
|
198
Prothena Corp
PRTA
$460M
| $47.2K | 0.01% |
691
-21
| -3% | -$1.43K |
|
|
FTCH
199
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $47.1K | 0.01% |
7,800
-50,000
| -87% | -$302K |
|
200
Intellia Therapeutics
NTLA
$1.29B
| $47.1K | 0.01% |
1,155
-37
| -3% | -$1.51K |
|